ChitogenX Inc (CSE:CHGX) CEO Philippe Deschamps joined Proactive's Stephen Gunnion with details of the company's plans to pursue sales of medical-grade chitosan as a new near-term commercial revenue initiative following the completion of an internal commercial and regulatory readiness process.
Deschamps telling Proactive that the company has a low-cost optimized GMP manufacturing process for the chitosan portion of its ORTHO-R product at its disposal and is ready to pursue additional commercial initiatives such as the sale of medical-grade chitosan.
#ProactiveInvestors #ChitogenX #chitosan #ORTHO-R #CSE